CompanyDeals

BiOneCure Therapeutics and Nanjing Leads Biolabs Collaborate on Innovative ADCs for Solid Tumors

CompanyDrug

Lynk Pharmaceuticals’ LNK01001 Demonstrates Efficacy in Phase II Rheumatoid Arthritis Study

CompanyDrug

Skyline Therapeutics Initiates Clinical Study with First Patient Dosing of SKG0106 for wAMD

CompanyDrug

Gracell Biotechnologies Initiates Trial for GC012F in Refractory SLE with Dual-Target FasTCAR Therapy

CompanyDeals

Aligos Therapeutics Partners with Amoytop Biotech for Oligonucleotide Compound R&D

CompanyDrug

CIM’s Cancer Vaccine CIMAvax Confirmed Immunogenic in US Study, Cuba Announces

R&D

COVID-19 Disruptions Lead to Soaring Lab Monkey Prices, Impacting US Drug Development

CompanyDrug

Huadong Medicine’s HDM1002 Receives FDA Approval for Clinical Trials

CompanyDeals

Rona Therapeutics and Keymed Biosciences Collaborate on siRNA Therapeutics for Glomerulonephritis

CompanyDeals

Omron Healthcare and JD Healthcare Form Partnership to Innovate Chronic Disease Management

CompanyDeals

LaNova Medicines and AstraZeneca Ink Global Licensing Deal for GPRC5D-Targeting ADC LM-305

CompanyDeals

ExoRNA Bio Secures Tens of Millions in Financing to Advance Huntington’s Disease Pipeline